Navigation Links
Glide Pharma Completes £14.0 Million ($21.4 Million) Fundraising for Scale Up of Drug and Device Manufacturing Processes and Product Development
Date:2/26/2013

p> solid dose injector

The Glide SDI® is an innovative needle-free delivery system. The reusable injector uses a spring mechanism to administer a tiny solid dosage below the patient's skin, where it dissolves and releases the pharmaceutical. Glide's solid dose formulations eliminate the risk of needle-stick injuries and avoid time-consuming reconstitution. They also have the potential to modify the release of medicines and to improve stability, removing the need for refrigeration. The one-click action, pen-sized device is extremely easy to use, with medicines supplied in pre-filled disposable cassettes, making it ideal for self administration. In clinical testing, volunteers strongly preferred the Glide SDI® to traditional needle and syringe.

About Glide Pharma

Glide Pharma is a pharmaceutical development and device company focused on the easy, safe and convenient administration of solid dose formulations of therapeutics and vaccines. The company has a range of in-house and partnered programmes based on its proprietary solid dose injector, the Glide SDI®. Glide Pharma has a strong management team with extensive experience of the pharmaceutical, biotechnology and medical device sectors. The company has successfully completed five investment rounds, and is supported by a consortium of institutional and private technology investors, including Invesco Perpetual, Oxford Technology Venture Capital Trusts, Oxford Capital Partners and Hygea VCT.

Contacts

Ian Smith
Chief Executive
Glide Pharma
Tel: +44-(0)8700-853-700

Rob Budge
RJB Communications
Tel: +44-(0)1865-760-969
Mobile: +44-(0)7710-741-241


'/>"/>
SOURCE Glide Pharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Verathon, maker of GlideScope video laryngoscopes, provides free educational DVD to promote best practices in pediatric airway management.
2. TriReme Medical, Inc. Receives FDA Approval for Glider™ PTCA Catheter
3. CPhI in Partnership With PMI India Announces Pharma Project Management Conference
4. UBM Launches PharmaEvolution.com, an Online Peer-to-Peer Network for Pharmaceutical Industry Professionals
5. Alexza Pharmaceuticals Corporate Presentation to Be Webcast at Three Upcoming Investor Conferences
6. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Monday, March 4
7. ShangPharma Corporation Announces Extraordinary General Meeting of Shareholders
8. DelMar Pharmaceuticals Announces $1.6 Million Closing in Private Placement
9. Simcere Pharmaceutical Group to Announce Fourth Quarter and Fiscal Year 2012 Financial Results on Thursday, March 7, 2013
10. Royalty Pharma Announces Proposal To Acquire Elan
11. Reckitt Benckiser Pharmaceuticals Inc. Receives FDA Response to Citizens Petition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014 MultiCell Technologies, Inc. (OTC Bulletin ... provisional patent application concerning composition of matter, biological targets, ... tumor cell death.  This patent application ... stranded RNA molecules (VSRNAs) which interfere with the basic ...
(Date:1/15/2014)... Jan. 15, 2014  According to Millennium Research Group ... intelligence, the United States ... markets will expand moderately through 2022, with embolization ... particular, increasing interest in drug-eluting beads (DEBs) and ...
(Date:1/15/2014)... Quebec , Jan. 15, 2014  Valeant Pharmaceuticals International, ... announced that the applicable waiting period under the Hart-Scott-Rodino ... the previously announced tender offer by its indirect wholly-owned ... outstanding shares of common stock of Solta Medical, Inc. ...
Breaking Medicine Technology:MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3
... Congressional Leaders to Introduce Legislation , WASHINGTON , ... Congressional Network (ACPCN) will join congressional leaders tomorrow to ... Savings Act." The bill by U.S. Rep. G.K. ... management (PBM) companies for medications. , "Congress is prepared ...
... AMD LASERS, the world leader in comprehensive and affordable ... Waclawik as Chief Operating Officer. In this newly created ... operations, procurement, production, quality assurance, and general financial oversight ... effort on the next-generation of product development in order ...
Cached Medicine Technology:Pharmacists Work with Congress to Address PBM Abuses 2AMD LASERS Announces the Addition of Bart Waclawik, New Chief Operating Officer 2
(Date:4/23/2014)... by a researcher from the Cancer Science Institute of ... has identified the cancer specific stem cell which causes ... developing new drugs for the treatment of this disease ... led by Dr Chan Shing Leng, Research Assistant Professor ... a cancer-specific variant of a cell surface protein, CD44v8-10, ...
(Date:4/23/2014)... may prevent the depletion of self-control, according to research ... the Association for Psychological Science. , Self-control can be ... focus attention on a boring textbook are hard things ... this difficulty: Exerting self-control for a long period seems ... subsequent tasks. , "It is as if self-control is ...
(Date:4/22/2014)... the New Jersey Institute of Technology (NJIT) today ... the launch of the New Jersey Innovation Institute ... model for business innovation through the leveraging of ... U.S. Senator Cory Booker, Panasonic Corp. of North ... Lieutenant Governor Kim Guadagno, New Jersey Secretary of ...
(Date:4/22/2014)... 2014 Researchers at UT Southwestern Medical Center are ... depression . , A team of physician-scientists at ... ghrelin (a hormone with natural anti-depressant properties) works inside ... new treatment for depression in the form of a ... study, published online in April,s issue of Molecular ...
(Date:4/22/2014)... 22, 2014) The International Communication Association will ... Seattle, Washington. The theme of the 2014 conference ... a networked and digital society. , Featuring over ... over 2,200 Communication scholars representing over 40 countries, ... communication conference in the world. This year,s conference ...
Breaking Medicine News(10 mins):Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 3Health News:ADHD drug may help preserve our self-control resources 2Health News:Government and industry leaders herald launch of NJIT's New Jersey Innovation Institute 2Health News:Depressed? Researchers identify new anti-depressant mechanisms, therapeutic approaches 2Health News:Depressed? Researchers identify new anti-depressant mechanisms, therapeutic approaches 3Health News:International Communication Association to hold Annual Conference in Seattle, Washington 2
... 4 (HealthDay News) -- The quality of family mealtimes ... research suggests. In the study, U.S. researchers observed ... children aged 5 to 12 with persistent asthma. ... or in a particular season, children with persistent asthma ...
... , FRIDAY, Feb. 4 (HealthDay News) -- The death of ... typically seen directed toward live infants, but it,s unclear whether ... may help improve understanding of how chimpanzees, one of humans, ... study authors noted. In the study, the researchers ...
... News) -- Safety labels that outline concerns about medications, ... within drug categories, a new study suggests. These ... a single class of drugs, according to a team ... team also advised that supplemental warnings (for example, following ...
... is blamed on a failure of innovative drive in the ... of venture capital to invest in early stage research, or ... , A research centre funded by the Economic and Social ... industry regulatory system must be an important part of the ...
... Gordon HealthDay Reporter , THURSDAY, Feb. 3 ... reduce symptoms of attention-deficit hyperactivity disorder (ADHD) in young ... the ages of 4 and 8 were placed on ... ADHD symptoms diminished in 78 percent of them. And, ...
... THURSDAY, Feb. 3 (HealthDay News) -- Although blacks make up only ... of all diagnosed cases of HIV, federal health officials reported Thursday. ... times that of whites, and the rate for black women is ... data from 37 states by the U.S. Centers for Disease Control ...
Cached Medicine News:Health News:Quality of Family Mealtimes May Affect Kids' Asthma 2Health News:'Black Box' Drug Warning Labels Applied Inconsistently: Study 2Health News:Tipping points -- the future of the pharmaceutical industry 2Health News:Restrictive Diet May Reduce ADHD Symptoms 2Health News:Restrictive Diet May Reduce ADHD Symptoms 3Health News:Restrictive Diet May Reduce ADHD Symptoms 4Health News: Burden of HIV Highest for Blacks, CDC Reports 2Health News: Burden of HIV Highest for Blacks, CDC Reports 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: